Nathalie Delesque

Sanofi (France)France

Medicine · Health Sciences

14h-index1.5kcitations20works0.02yr avg

Accepting Students?

No reports yet. Know if this professor is taking students?


Research Topics

Neuroendocrine Tumor Research Advances(12), Protein Tyrosine Phosphatases(8), Angiogenesis and VEGF in Cancer(3), Glycosylation and Glycoproteins Research(3), PI3K/AKT/mTOR signaling in cancer(3)

Publications20 total

VEGF Trap Exhibits VEGF Binding Stoichiometry Distinct From Antibodies, and Does Not Support Platelet Aggregation
Investigative Ophthalmology & Visual Science·2012
Novartis Foundation symposium·2007· 16 cited
Biochemical and Biophysical Research Communications·2001· 270 cited
Proceedings of the National Academy of Sciences·1997· 138 citedOpen Access
sst2 somatostatin receptor expression reverses tumorigenicity of human pancreatic cancer cells.
PubMed·1997· 105 cited
Characterization of the antiproliferative signal mediated by the somatostatin receptor subtype sst5 (cyclic GMPycholecystokinin receptorymitogen-activated protein kinaseysomatostatin analogue RC-160ydecreased cell growth)
1997
Journal of Clinical Investigation·1996· 52 citedOpen Access

Frequent Co-authors

Louis Buscail(13), Nathalie Saint‐Laurent(11), Nicole Vaysse(11), J.P. Estève(8), Christiane Susini(8), Andrew V. Schally(5), C. Susini(5), Pierre Savi(4), Frédéric Lopez(4), Isabelle Rauly(4), Françoise Bono(4), Jean‐Marc Herbert(3), Jean‐Pierre Estève(3), Corinne Bousquet(3), Graeme I. Bell(2), Pierre Cordelier(2), Philippe Rochaix(2), Jean-Pascal Hérault(2), M. Zeggari(2), Douglas MacDonald(2)